Annual Report

Overview

The report describes Peijia Medical's 2024 Group revenue growth to RMB615.5 million, alongside a Board-led ESG governance structure. It reports zero work-related deaths and states that the Group and its employees were not involved in corruption, bribery, extortion, fraud or money-laundering cases during the year.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Publication date: 25 March 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services